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1. Introduction  
Epilepsy is a major neurological disorder that affects 0.5-2.0% of the global population 
(Hauser, 1998; Picot et al.; 2008). The term “epilepsy” likely encompasses a number of 
various etiological and pathophysiological processes. The International League Against 
Epilepsy (ILAE) has classified the epilepsies as being either focal or generalized. In all 
likelihood, this classification implies different causes and anatomical/functional substrates. 
Epileptogenesis (the processes by which epilepsy develops within an otherwise normal 
brain) probably differs for the various types of epilepsy (Lüders, 2008). In this sense, 
epileptogenesis of (for example) temporal lobe epilepsy (TLE) with hippocampal sclerosis 
(HS), would be different from that observed in patients with cortical dysplasia; this would 
hold true for other cryptogenic or idiopathic focal epilepsies as well. Therefore, to date, it 
has not been possible to establish a unique underlying cause or mechanism that is involved 
in the transition from normal to epileptic cortical tissue, although there are several 
hypotheses to explain the different types of seizures and epilepsies. 
From a therapeutic point of view, the epilepsies in humans can be divided into pharmaco 
sensitive and pharmaco resistant. In the former, the patient is successfully treated by one or 
more anti-epileptic drugs (AED). Nearly two-thirds of patients respond to anticonvulsant 
therapy. However, in a significant percentage of patients, the seizures cannot be controlled 
by drugs, despite verifying both maximal dosage and an adequate treatment duration. The 
percentages of medical intractability among epileptic patients are: focal epilepsy, 24%; 
idiopathic epilepsy, 9.3%; and catastrophic epilepsy, 66.7% (Lardizabal, 2008). In some cases, a 
viable therapeutic option is surgery. Generally, the candidates for this treatment are patients 
who suffer from focal or partial epilepsy. In these patients, it is possible—at least in theory—to 
identify a well-defined area of the cortex that is responsible for the seizures; this is known as 
the epileptic zone (EZ). From an operational point of view, the EZ is defined as the region in 
which excision or disconnection relieves the patient from seizures. This option frequently 
involves removing the brain section where the EZ is located, and this possibility offers a 
unique opportunity to gain access to the real processes (the neural networks, membrane 
properties and synaptic dynamics) underlying partial epilepsy in human patients.  
TLE is the most common form of partial epilepsy in adults and is usually drug-resistant 
(Engel 2001; Wieser, 2004). This type of pathology is frequently associated with a salient 
pathological condition called hippocampal sclerosis (see Figure 1 -Kuzniecky et al.; 1987). 
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For several decades, HS has been considered the source of the electrical events that cause 
spontaneous seizures (Falconer, 1974; Spencer 1998). However, HS is found in 
approximately 40-65% of patients who undergo surgery for TLE (de Lanerolle et al.; 2003), 
and whether hippocampal sclerosis is the cause or the consequence of repeated seizures is 
still a matter of debate (Jefferys, 1999; Boison, 2008). The progression of epileptogenesis to 
chronic epilepsy often leads to pharmacoresistance and affects up to 30% of all patients with 
epilepsy, particularly those with TLE (Engel, 2001). 
A wide range of brain injuries and brain lesions are associated with an increased risk of 
epilepsy. In fact, such symptomatic etiologies account for 30-49% of all unprovoked seizures 
and epilepsy (Herman, 2002). The most common risk factors are cerebrovascular disease 
(21%), tumor (11%) and traumatic brain injury (7%) (Forsgren, 1990). A feature that is 
common to all of these conditions is the compromised permeability of the blood-brain 
barrier (BBB). Although idiopathic epilepsy accounts for up to 65% of cases, these patients 
likely share some pathophysiological mechanisms with injury-induced epilepsies. 
Much is known regarding neuronal electrophysiology in epileptic tissues (Avoli et al.; 2005; 
Pastor et al.; 2006); however, there is little information regarding the transition from a 
normal brain to an epileptic brain. Recently, it was shown in both rats and humans that 
astrocytes could be involved in some types of partial seizure (de Lanerolle et al.; 2010). 
Astrocytes are situated in key pivotal places that may play a role in epilepsy in several 
ways. Indeed, astrocytes control the trafficking of substances between capillary vessels and 
neurons. Another important function is in the homeostasis of extracellular ions, principally 
potassium (K+), which is directly involved in neuronal excitability. Finally, astrocytes are 
mediators of the neuron–to-neuron synapse through the tripartite synapse. In addition to 
astrocytes, another important factor is a change in the permeability of the BBB, which is 
formed by endothelial cells, although glial cells contribute yet to its function. 
 
 
Fig. 1. Microphotograph of a Nissl-stained hippocampus obtained from a patient who 
underwent surgery for TLE. A loss of cells is evident in the CA1, CA3 and hilus regions. 
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Albumin, the most abundant protein in blood, has also been implicated in epileptogenesis 
(Seiffert et al.; 2004; Herrera-Peco et al.; 2008) together with changes in BBB permeability or 
the inflammatory cascade, although the role of these mechanisms in epilepsy are still poorly 
understood (de Lanerolle et al.; 2010). Although not conclusive, different results point to 
astrocytes as being important mediators of the mechanisms involved in epileptogenesis and 
the origin and spreading of seizures. In this chapter, we review some of the recent theories 
and results concerning these topics, with a special emphasis on results obtained from 
human patients. We shall analyze the role of BBB permeability in the leakage of albumin 
into the brain’s extracellular space and the possible role of this protein in the activation of 
astrocytes. Although other reviews have focused on the role of the TGF-ǃ receptor (TGF-ǃR) 
in the action of albumin, we shall review a putative role for a different albumin receptor that 
is currently not well characterized but clearly has different properties than TGF-ǃR. 
2. A brief introduction to astrocyte physiology  
Glial cells outnumber neurons by approximately 10-50:1. Glial cells can be divided into two 
major classes called microglia and macroglia. 
• Microglia are phagocytes that mobilize in response to brain injury (for example, 
infection or disease). From a physiological and embryological point of view, they are 
unrelated to the others cells of the nervous system. Microglia are activated and 
recruited during infection, seizure and injury or disease, including multiple sclerosis, 
stroke, acquired immunodeficiency syndrome (AIDS)-related dementia and Parkinson’s 
disease. In this regard, microglia serve as major antigen-presenting cells. 
• Macroglia comprise three different types of cells: 
• Oligodendrocytes and Schwann cells are located in the Central Nervous System 
(CNS) and Peripheral Nervous System (PNS), respectively. Both cell types provide 
insulation for neuronal axons. Each oligodendrocyte envelops an average of 15 
axonal internodes. However, each Schwann cell envelops only one internode on a 
single axon. The insulation provided by these cells is necessary for saltatory nerve 
conduction (Donaldson & Mia-Sin Wu, 2001). 
• Astrocytes are the most numerous glial cells and tend to have long processes, some 
of which terminate as end-feet on the surface of neurons and, among other things, 
supply nutrients. Some astrocytes project their end-feet to capillaries, where they 
help endothelial cells form the BBB. However, their exact definition and the types 
of astrocytes that exist remain incompletely understood (Haydon & Carmignoto, 
2006; de Lanerolle et al.; 2010). 
Traditionally, the main role of astrocytes has been considered to be to provide support to 
neurons (Barres, 1991). However, over the previous decades, astrocytes have been found to 
play several roles other than supportive. Seminal works showed that astrocytes express 
receptors for neurotransmitters (Porter & McCarthy, 1997) and can respond to a local 
application of glutamate with a calcium elevation that travels as a wave through a 
syncytium (Corner-Bell et al.; 1990). Together, these data suggest that astrocytes possess the 
capacity to signal using spike-like calcium transients. In fact, these calcium spikes can travel 
over long distances and serve as a tool for communication.  
Astrocytes are normally identified by their expression of glial fibrillary acidic protein 
(GFAP). However, glial cells can be further categorized according to their functional 
properties as follows (Matthias et al.; 2003, Wallraff et al.; 2004; Jabs et al.; 2008):  
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• Cells with large outward K+ current and attenuated inward K+ current (IKir). The resting 
potential (Vr) of these cells is therefore relatively depolarized (∼-31 mV). Most of these 
cells contain TTX-sensitive Na+ currents but are unable to generate action potentials. 
These cells express alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
(AMPA) type receptors (GluR), but not glutamate transporter currents. Finally, these 
cells completely lack gap junction coupling but receive spontaneous synaptic input 
from glutamatergic and Ǆ-aminobutyric acid neurons (GABAergic).  
• Cells that resemble protoplasmic astrocytes. These cells have a more negative Vr (∼-70 
mV), and IKir is present. These cells express glutamate transporter currents (GluT) but 
not GluR currents. Finally, these cells are extensively coupled via gap junctions. 
• A third cell type closely resembles the GluR cell type described above. These are 
considered a third class of macroglia and have various names, including neuron glia-2 
(NG2) cells, oligodendrocyte precursor cells, polydendrocytes, synantocytes and 
complex cells (Pauker & Bergles, 2006). These cells express chondroitin sulfate 
proteoglycan, do not express GFAP and lack GluT currents and gap junctions. As with 
GluR astrocytes, they express AMPA receptors as well as GABA receptors; moreover, 
they receive synaptic terminals. Current injection into these cells elicits action potentials 
that are reversibly blocked by TTX. To complicate matters further, two classes of NG2 
cells have been recently identified (Káradóttir et al.; 2008): one class expresses voltage-
gated Na+ currents together with voltage-gated K+ currents, whereas the other does not 
express Na+ currents. Presumably, both of these cell classes additionally express 
voltage-gated Ca2+ currents. 
2.1 Plasma membrane properties of astrocytes 
Some astrocytes exhibit a high resting K+ conductance and possess gap junction coupling; 
thus, the first major function that was assigned to these cells was the clearance of 
extracellular K+ following neuronal activity. However, glial cells express a set of receptors 
that is similar to neurons, but at different relative densities. This suggests that astrocytes 
perform other functions than buffering K+. Among their intrinsic membrane proteins are 
metabotropic glutamate receptors (mGluR) (Zur Nieden and Deitmer, 2006), purinergic 
receptors (Jeremic et al.; 2001) and GABA type-B receptors. Other ionotropic receptors, such 
as AMPA, are also present. An elevated amount of GluR1 in the AMPA receptors of reactive 
astrocytes has been reported, which suggests an increased responsiveness of these astrocytes 
to glutamate (Seifert et al.; 2004). This change has been observed in astrocytes that were 
obtained from sclerotic tissue. Moreover, in animal models, mGluR3, mGluR5 and mGluR8 
up-regulation has been reported in the hippocampus (Steinhäuser & Seifert, 2002). These 
receptors are involved in the astrocyte’s response to glial and neurotransmitter. During 
normal brain function activity, astrocytes play a major role in the clearance of glutamate that 
is released from the nerve terminal into the extracellular space.  
Astrocytes achieve this through the activity of two glutamate transporter molecules, namely 
the excitatory amino acid transporter (EAAT) subtypes EAAT1 and EAAT2 (de Lanerolle et 
al.; 2010). The GABA transporter GAT3 is usually only weakly expressed (if at all) in 
astrocytes. Aquaporin 4 (AQP4) is a water transporter molecule that is found on astrocytes. 
The distribution of these transporter molecules is asymmetric, being more densely 
expressed on the perivascular astrocytic end-feet than on the membrane that faces the 
neuropil (de Lanerolle et al.; 2010). 
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Several studies demonstrated the presence of voltage-dependent ionic channels, including 
Na+, K+ and Ca2+ channels (Barres et al.; 1990; Sontheimer et al.; 1991; Sontheimer & 
Waxman, 1993). Voltage-gated Na+ channels are present in astrocytes in various brain 
regions. It has been postulated that this might serve to regulate [Na+]i and thereby control 
the activity of the Na+/glutamate transporter or Na+/K+ ATPase exchanger (Sontheimer et 
al.; 1994). Calcium channels have also been identified in both cultured astrocytes and acute 
astrocyte preparations (Verkhratsky & Steinhäuser, 2000). Astrocytes play a major role in K+ 
homeostasis in the central nervous system. During neuronal activity, [K+]o is temporally 
increased, which depolarizes nearby membranes. Astrocytes help move K+ away from 
regions of high concentration to restore the normal extracellular concentration (Steinhäuser 
& Seifert, 2002). Inwardly rectifying potassium (Kir) channels in astrocytes play a major role 
in removing K+ from the extracellular space.  
2.2 Calcium signaling in astrocytes 
Glial cells respond with changing [Ca2+]i to various neurotransmitters, the most important of 
which are glutamate, ATP, adenosine and GABA (Haydon & Carmignoto, 2006). These 
transmitters activate metabotropic receptors that are coupled to second messenger systems.  
Astrocytes not only exhibit changes in [Ca2+]i after extracellular neurotransmitter release, 
but spontaneous calcium oscillations can also occur in the absence of neuronal activity (Nett 
et al.; 2002; Parri & Crunelli 2003; Zur Nieden & Deitmer, 2006). It has been established that 
both evoked and spontaneous astrocyte calcium increases depend on calcium release from 
internal stores (Fiacco & McCarthy, 2006). A neurotransmitter-induced increase in astrocytic 
calcium activates astrocytic metabotropic Gq-coupled receptors that drive the release of 
calcium from the endoplasmic reticulum (ER) upon activation of phospholipase C (PLC) 
and conversion of phosphotidylinositol bisphosphate to inositol triphosphate (IP3) (Nadal et 
al.; 1995; Porter & McCarthy, 1996; Araque et al.; 1998a, Newman 2005; Pastor et al.; 2010). 
Spontaneous [Ca2+]i changes are not completely understood, but some theories that are 
supported by various experimental data have been postulated. These include a mechanism 
involving voltage-gated calcium channels and calcium induced-calcium release (Parri & 
Crunelli, 2003), activation of mGluR by the quantal release of small amounts of glio or 
neurotransmitters (possibly spillover from synaptic region) (Zur Neider & Deitmer, 2006) 
and a “switch” in the intrinsic activity of metabotropic receptors (Pasti et al.; 1997). 
Although the ryanodine receptor has been implicated in calcium changes in epilepsy 
(Tashiro et al.; 2002), its role has not yet been clarified because several studies failed to show 
any significant contribution in astrocytes that were obtained from epileptic patients (see 
Figure 2 and reference Pastor et al.; 2010). 
In astrocytes, a local calcium increase following IP3 receptor activation often propagates as a 
‘‘calcium wave’’ some distance from its point of origin (Nadal et al.; 1997). The propagation 
of calcium waves is believed to occur via calcium diffusing locally (after its initial release) to 
neighboring IP3 receptors, where it acts as a co-agonist with IP3 to release stored calcium 
from adjacent compartments (Fiacco & McCarthy, 2006). 
Upon stimulation, astrocytes in culture display a calcium wave that propagates 
intercellularly through thousands of cells (Cornell-Bell et al.; 1990). The mechanisms that are 
involved in the propagation of intercellular calcium waves in cultured astroglia include: (1) 
gap junctions between astrocytes that allow the intercellular diffusion of second messengers 
such as IP3, and (2) the calcium-induced release of ATP that diffuses extracellularly to 
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neighboring astrocytes to activate purinergic receptors that are coupled to internal calcium 
stores (Cotrina et al.; 2000; Suadicani et al.; 2004). There is no evidence of the existence of 
intercellular astrocyte calcium waves in intact tissue, suggesting that long-range glial 
signaling may be an artifact of cultured astroglia; however, it has been proposed that this 
process might occur in pathological conditions such as epilepsy (Peters et al.; 2003). In 
general, these observations suggest that widespread intercellular calcium waves are not 
likely to occur between astrocytes under physiological conditions in situ. However, a recent 
in vivo study showed that “Ca2+ signals (…) can propagate through the cell and couple to 
adjacent astrocytes in the form of a Ca2+ wave” (Ding et al.; 2007). 
These changes in [Ca2+]i can act as a second messenger in various cellular process, including 
the release of gliotransmitters or the modification of gene expression patterns. 
 
 
Fig. 2. Ryanodine fails to block the response to bovine plasma albumin (Alb; 20 mg/ml) in 
astrocytes obtained from epileptic patients (unpublished data). 
2.3 Interactions between astrocytes and neurons 
Astrocytes were initially considered to be supportive cells. However, during the last years 
of the past century, it became clear that glial cells can also contribute to information 
processing by neurons. Various studies have led to the proposal of the “tripartite 
synapse”, in which the astrocyte monitors synaptic activity and provides feedback by 
modulating the strength of the synaptic connection (Araque et al.; 1999; 2001). This 
concept is based on studies showing that glial cells respond to neuronal activity with an 
[Ca2+]i increase, which in turn triggers the release of gliotransmitters that can cause 
feedback regulation of neuronal activity. 
Calcium increases in astrocytes are coupled to the regulated release of neuroactive 
molecules and classic neurotransmitters that include ATP, inflammatory cytokines, 
vasoactive compounds, D-serine and glutamate (Parpura et al.; 1994 ; Coco et al.; 2003 ; 
Zonta et al.; 2003; Mothet et al.; 2005). 
Other modes of glutamate release by astrocytes are calcium-independent and include 
release through large pores, including gap junction hemi-channels and purinergic P2X7 
receptors (Ye et al.; 2003; Fellin et al.; 2006), a reversal of glutamate transport (Anderson & 
Swanson, 2000) and by volume-sensitive anion channels (Takano et al.; 2005). However, 
calcium-independent modes of astrocytic glutamate release have only been observed under 
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pathological conditions, such as severe energy depletion, highly increased external K+ and 
in divalent cation-free extracellular solutions. Therefore, a considerable body of data 
suggests that the calcium-dependent release of glutamate from astrocytes occurs via a 
regulated exocytotic vesicular mechanism. 
It has been shown that synaptotagmin 4 is essential for Ca2+-dependent glutamate release. 
Presumably, an excess of the synaptotagmin isoform 4 in place of isoform 1 suggests that the 
kiss-and-run release mechanism prevails over full vesicle fusion (Wang et al.; 2001). 
Moreover, several studies demonstrated the presence and participation of SNARE proteins 
in exocytosis (Araque et al.; 2000). 
Glutamate release likely acts through NMDA receptors (NMDARs) that are composed of 
NR1/NR2B subunits. These receptors are located extrasynaptically, whereas in the synaptic 
membrane, the NR1/NR2A configuration is found (Haydon & Carmignoto, 2006).  
This situation of NMDAR can account for the high amplitude and slow kinetics of the slow 
inward currents (SIC; see Figure 3) that are recorded after astrocytic glutamate release  
(∼100 pA), whereas synaptic currents are only around 2-3 pA in amplitude. In addition to 
exerting kinetic differences, synaptic and extrasynaptic NMDA receptors may accomplish 
different—and to some degree opposing—functional roles (Krapivinsky et al.; 2003). 
It has been suggested that the release of glutamate from a single astrocyte has the potential 
to act synchronously on several different dendrites. Indeed, this mechanism may underlie 
the generation of paroxysmal depolarization shifts (PDS) that can be induced in several 
neurons in a rat model of epilepsy. Besides NMDARs, AMPA receptors (AMPARs) may also 
be activated by astrocytic glutamate release. These receptors are also present at 
extrasynaptic locations, and their activation may serve as a type of coincidence detector with 
synaptic NMDARs (Haydon & Carmignoto, 2006). 
 
 
Fig. 3. Astrocytes can activate neurons by gliotransmitter release. A) Infrared differential 
interface contrast (DIC) image showing the stratum radiatum (SR) and the recorded neuron 
in the stratum pyramidale (SP) of a rat hippocampal slice. B) Whole-cell currents from a 
CA1 pyramidal neuron showing a neuronal slow inward current (SIC, expanded in the 
bottom trace). Courtesy of Dr. Alfonso Araque, Consejo Superior de Investigaciones 
Científicas, Madrid. 
Glutamate is not the only molecule that is released from astrocytes to modulate the activity 
of neurons. Other molecules are functionally important as well. In fact, in addition to 
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requiring glutamate for NMDAR activation, the co-agonist D-serine may also be important. 
Astrocytes are the only cells that express the enzyme serine racemase, making glial cells the 
only source for this molecule in the brain (Wolosker et al.; 1999). It has been suggested that 
vesicles might contain both D-serine and glutamate, thereby allowing their simultaneous 
release upon increased [Ca2+]i (Haydon & Carmignoto, 2006). 
Another important gliotransmitter that is released by astrocytes is ATP, and the mechanisms 
that are involved are the subject of debate. There is evidence that the release of both ATP 
and glutamate involve phospholipase C, but it has been suggested that ATP release depends 
on the diacylglycerol pathway (Wang et al.; 2000), although this hypothesis is still under 
debate. Released at micromolar concentrations ATP has powerful effects on adjacent 
neurons acting through purinergic receptors (P2). ATP can activate P2 presynaptic receptors. 
In fact, the activation of P2Y1 receptors in CA1 interneurons—most likely after the release of 
ATP from both neurons and astrocytes—may induce action potentials in these neurons and 
lead to increased GABAergic synaptic inhibition of pyramidal neurons (Bowser & Khakh, 
2004). However, an excitatory effect of ATP has been described in which glutamate-
mediated miniature end-plate synaptic currents are increased (Gordon et al.; 2005). Once 
ATP has been released into the extracellular space, a variety of ectonucleotidases degrade 
ATP into adenosine. Adenosine is a ubiquitous modulator of synaptic transmission and 
neuronal activity and acts through specific receptors. Indeed, there are high-affinity 
inhibitory adenosine A1 and excitatory A2A receptors that are activated by nanomolar 
concentrations of adenosine as well as low-affinity or low-abundance A2B and A3 receptors. 
The most relevant function of adenosine is to induce presynaptic inhibition of transmitter 
release and therefore has potent anticonvulsant and neuroprotective functions (Boison, 
2008). It is important to note that adenosine—either released or produced by ATP 
degradation—can diffuse from the synaptic cleft and act laterally to regulate the strength of 
neighboring synapses in a mechanism named heterosynaptic suppression, which is 
mediated by the accumulation of adenosine acting through A1 receptors (Zhang et al.; 2003). 
We will see below in detail the effect of adenosine on seizure threshold (see 4.5 The role of 
adenosine kinase in epileptogenesis); however, suffice it to say that adenosine acting 
through A1 receptors has a potent anticonvulsant effect. 
In addition to the release of gliotransmitters, it is important to consider that one cortical 
astrocyte makes contacts with approximately 300-600 neuronal dendrites. These “local 
modules” of astrocytic integration can affect the function of several groups of neurons or 
synapsis, thus working in a more coherent mode (Halassa et al.; 2007). 
Astrocytes play an important role in the metabolism of the brain through their exclusive role 
in the degradation of both glucose and glutamate. The importance of astrocytes in these 
processes lies in their expression of key enzymes that are not normally found in neurons. Of 
course, these processes are extremely important for appropriate brain function but are 
beyond the scope of this review. The reader is referred to Hertz et al. (1999) and Herrera-
Peco et al. (2008). 
2.4 Astrocytes are activated by albumin 
Albumin (C123H193N35O37) is the most abundant protein in blood, representing more than 
50% of all proteins. Its molecular weight is 2754.06 g/mol, and its concentration in plasma is 
around 35-55 mg/ml (Nadal et al.; 2001). Among its functions is the binding of several polar 
lipids, particularly lysophosphatidic acid (LPA), other fatty acids and sphingomyelins that 
are derived from platelet activation (Fuentes, E.t al.; 1999). Albumin is also the main 
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component in maintaining osmotic plasma pressure. Thus far, albumin has been shown to 
activate various cell types, including rat astrocytes in culture (Nadal et al.; 1995; 1997) and in 
brain slices (Ivens et al.; 2007; Nadal et al.; 1998).  
Depending on its concentration, plasma albumin—that is, albumin obtained from non-
clotted blood—can have a dual effect on astrocytic [Ca2+]i. A low albumin concentration can 
induce a decrease in calcium, whereas higher doses increase [Ca2+]i in a dose-dependent 
manner (Figure 4). These effects, which were initially studied in astrocytes obtained from rat 
pups, were recently demonstrated in humans (Pastor et al.; 2010).  
The dual effect on cytosolic calcium in astrocytes depends on two different components of 
native plasma albumin that can be separated by methanol extraction (Nadal et al.; 1994; 
1995). The protein component of albumin causes a reduction in [Ca2+]i, whereas native 
albumin—to which the lipid factor is normally attached—induces repetitive calcium spiking 
and DNA synthesis in addition to decreased [Ca2+]i. This factor cannot be a protein 
contaminant such as a growth factor because its activity can be extracted by methanol 
through a dialysis membrane, is sensitive to lipases but not boiling and can be reconstituted 
with extracted albumin to restore the full activity of native albumin. The preferential 
extraction by methanol suggests that the factor is a polar lipid such as a phospholipid or 
ganglioside (Nadal et al.; 1995). This polar lipid has not yet been identified, but it has been 
suggested that it might be the same substance that binds to glia cell stimulating factor (GSF) 
(Nuñez & García-Sancho, 1996). 
 
 
Fig. 4. Changes in [Ca2+]i in human astrocytes induced by bovine plasma albumin (BPA). 
The bars indicate the application of glutamate (Glu 500 mM) or BPA at the indicated 
concentrations (in mg/ml). Note that 0.1 mg/ml BPA induced a decrease in fluorescence. 
The microphotographs show the changes in [Ca2+]i of one human astrocyte (arrow) to BPA. 
The numbers at left indicate the albumin concentration. The cells were loaded with Fura-2 
AM (10-6 mol/L). Unpublished data. 
As is the case with other neurotransmitters, the change in [Ca2+]i depends on the release of 
IP3 after G-protein-mediated activation of PLC (Nadal et al.; 1995; 1997; Pastor et al.; 2010). 
The albumin receptor has not yet been identified. 
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In addition to its effects on cytosolic calcium, plasma albumin can also induce the synthesis 
of DNA. This process of synthesis is the normal precursor to mitosis, which implies that 
albumin can act as a mitogen in astrocytes. 
In addition to the calcium pathway that is activated by albumin, this protein is also taken 
up by astrocytes, neurons and microglia (albeit to a lesser extent) (Ivens et al.; 2007; van 
Vliet et al.; 2007). This effect of albumin on glial cells is mediated by the TGF-ǃR (TGF-ǃR; 
Figure 5), which activates the Smad signaling pathway (Cacheux et al.; 2009). This 
mechanism of activation has been extensively studied in a rat model of epilepsy and is 
discussed below in detail. 
An important question regarding the type of albumin (either plasmatic or serum) remains 
unanswered. In fact, both models, the albumin-receptor activated and the TGF-βR, have 
been described with plasma albumin (Nadal et al.; 1995; Pastor et al.; 2010) and serum 
albumin (Seiffert et al.; 2004; Ivens et al.; 2007) respectively. In the latter case, albumin 
carries different lipids that are derived from the coagulation cascade, including 
lysophosphatidic acid (LPA), lysophosphatidylcholine, sphingomyelin and platelet-
activating factor. All of these lipids can elicit calcium signals of varying magnitude in 
cortical astrocytes, although only LPA-induced calcium signals are comparable in amplitude 
to those induced by the active physiological lipid that is bound to plasma albumin. None of 
these lipids, however, was found to cause cell division in astrocytes (Fuentes et al.; 1999). 
There is therefore no direct invariable relationship between the ability of lipids to induce 
calcium signals and mitogenic activity. Perhaps under pathologic conditions, coagulation 
plays an important role in the effect of albumin on astrocytes; nevertheless, albumin would 
be attached to a polar lipid that has an effect distinct from LPA. 
 
 
Fig. 5. Mechanisms of action of albumin in astrocytes. Depicted is the IP3-cytosolic calcium 
pathway with its proposed effect on gene transcription, indicated by the asterisk. TGF-ǃR 
signaling pathway is also shown. Both of these pathways are present in cultured human 
astrocytes. * Hypothesized action. See text for more details. 
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3. The structure and function of the blood-brain barrier  
The BBB is a diffusion barrier that impedes the influx of most compounds between the 
blood and the brain, thereby isolating the brain from the external environment. Three 
cellular elements of the brain’s microvasculature comprise the BBB and are responsible for 
its properties. These components are:  
• Endothelial cells. Tight junctions (TJs) are special transmembrane proteins that are 
located between cerebral endothelial cells, where they form a diffusion barrier that 
selectively excludes most blood-borne substances from entering the brain. There is 
some evidence of cross-talk with astrocytes. Indeed, endothelial cells seem to be the 
primary source of leukemia inhibitory factor (LIF), which helps induce astrocyte 
differentiation (Mi et al.; 2001). Other molecules that are presumably released by 
endothelial cells to affect astrocytes include bradykinin and glutamate. Moreover, 
endothelial cells are involved in neurogenesis, primarily via vascular endothelial 
growth factor (VEGF) (Loussaint et al.; 2002). 
• Astrocyte end-feet. These structures tightly ensheath the vessel wall and appear to be 
critical for the induction and maintenance of the TJ barrier, although astrocytes are not 
believed to have a role in the mammalian BBB. However, astrocytes are important 
because they help induce the generation of BBB structures in endothelial cells. Astrocytes 
can act on endothelial cells by releasing cytokines such as TGF-β and glial cell-derived 
neurotrophic factor (GDNF) (Utsumi et al.; 2000, Ramsauer et al.; 2002). Intracellular 
calcium waves mediate bidirectional astrocyte-endothelial interactions. In co-culture 
models, two signaling mechanisms are presumably involved: 1) astrocytes and 
endothelial cells can exchange calcium signals via a pathway that is dependent on 
intracellular IP3 and gap junctions; and 2) diffusion of a purinergic messenger. However, 
in vivo, astrocytes and endothelial cells are not in contact, and therefore, these findings 
need to be confirmed. Nevertheless, the dilation of arterioles triggered by neuronal activity 
depends on glutamate-mediated [Ca2+]i oscillations in astrocytes (Zonta et al.; 2003). 
• Pericytes are undifferentiated cells that wrap around the endothelial cells of 
microvessels, including capillaries, venules and arterioles. Pericytes are believed to 
provide structural support and vasodynamic capacity to the microvasculature (Ballabh 
et al.; 2004). Pericytes can also help to stabilize capillaries that are recently formed by 
endothelial cells, thereby regulating angiogenesis (Balabanov & Dore-Duffy, 1998). 
The BBB differs from endothelial cells in the rest of the body by the absence of fenestrations, 
extensive tight junctions (TJs) and bare pinocytic vesicular transport. The building blocks of 
the BBB are comprised of several molecules and subcellular structures that confer its unique 
properties, the most important of which are: 
• Complex junctions in the BBB are formed by TJs and adherens junctions. Tight junctions 
are sites of apparent fusion between leaflets of the plasma membranes of adjacent cells, 
whereas adherens junctions are composed of cadherin-catenin complexes and their 
associated proteins (Matter & Balda, 2003). Cytoplasmic proteins link membrane 
proteins to actin, which is the principal protein of the cytoskeleton. 
• Tight-junction–associated membrane proteins, including occludins, claudins and 
junctional adhesion molecules (Furuse et al.; 1993; Martin-Pardura et al.; 1998; Morita et 
al.; 1999). These proteins form the extracellular component of TJs.  
• Cytoplasmic accessory proteins, including zonula occludens (ZO) proteins, cingulin 
and several others (Itoh et al.; 1999). Actin binds to ZO proteins, thereby providing 
structural support to the endothelial cells (Haskins et al.; 1998). 
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Dysfunction of the BBB exacerbates a number of neurologic diseases, including stroke and 
neuroinflammatory disorders. Under pathological conditions, different chemical mediators 
that increase BBB permeability are released. Among these mediators are glutamate, 
aspartate, taurine, ATP, endothelin-I, tumor necrosis factor (TNF)-α and interleukin-1β  
(IL-1β), all of which are produced by astrocytes (Kutsova et al.; 1999; Abbot 2000; 2002). 
Moreover, endothelial cells can release bradykinin, 5-HT, histamine, substance P, platelet 
activating factor and free radicals (Abbot, 2002; St’astný et al.; 2000). 
The function of the BBB is to control the traffic of substances between the blood and the 
brain. This is achieved in three ways: 
• Diffusion of lipid-soluble substances. The BBB permits the rapid exchange of lipid-
soluble gases such as O2 and CO2, an exchange that is limited only by the surface area of 
the blood vessel and cerebral blood flow. Barrier vessels are impermeable to molecules 
that are poorly soluble in lipids. The permeability coefficient of the BBB for many 
substances is directly proportional to the lipid solubility of the substance, which is 
measured as its oil-water partition coefficient (Laterra & Goldstein, 2000). 
• Facilitated and energy-dependent receptor-mediated transport of specific water-soluble 
substances. Most substances that must cross the BBB are not lipid soluble and therefore 
need a specific carrier-mediated transport system. One of the most important 
substances is glucose, which is transported by the glucose transporter isotype-1, or 
Glut1 (Guerin et al.; 1999). Amino acids are also transported by three distinct carrier 
systems. Another transport system is related to the multidrug resistance to 
chemotherapy (MDR) transporter (Schinkel et al.; 1994).  
• Ion channels. Various studies support the existence of a nonselective luminal ion 
channel that is inhibited by both amiloride and atrial natriuretic peptide. The existence 
of luminal Na+/H+ and Cl-/HCO3- exchangers has also been suggested. The external 
membrane of brain endothelial cells contains a relatively high density of Na+/K+-
ATPase pump. In conjunction with K+ channels in astrocytes, this abluminal endothelial 
pump may play an important role in removing extracellular K+ that is released during 
intense neuronal activity. In addition, the nonselective luminal ion channel, a distinct 
abluminal K+ channel and the abluminal Na+/K+-ATPase may work together to tightly 
regulate the entry of Na+ and the release or recycling of K+ (Haydon & Carmignoto, 
2006). Aquaporin-4 is the major water channel expressed in brain perivascular 
astrocytic processes and is the principal system for regulating the traffic of water 
between the brain and blood. Thus, its role in cerebral edema is very important.  
4. The role of astrocytes in epileptogenesis 
Until recently, little was known regarding the process by which a normal brain becomes 
epileptic following an external or internal insult, for example following traumatic brain 
injury or seizures that are induced by fever or infectious disease. These symptomatic 
epilepsies account for a significant number of patients; however, for patients with idiopathic 
or cryptogenic epilepsy, the antecedents remain unknown. In general, except for well-
defined etiologies (e.g.; cortical dysplasia), the brain’s transition from normal to epileptic—
namely, epileptogenesis—remains obscure. 
However, several lines of evidence involving astrocytes have begun to emerge during the 
last decade, providing a somewhat coherent framework. These lines of evidence can be 
grouped according to the different structures that are involved. 
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4.1 Modification of astrocyte membrane proteins 
Diverse changes have been described for the expression of intrinsic plasma membrane 
proteins in astrocytes at the epileptic seizure foci. 
In sclerotic hippocampi, reactive astrocytes express mGluR2/3, mGluR4 and mGluR8. 
Similarly, mGluR3, mGluR5 and mGluR8 are up-regulated in the hippocampus in 
experimental animal models of TLE. Activation of these receptors may lead to an increase in 
[Ca2+]i and Ca2+ wave propagation, thereby leading to the release of glutamate from 
astrocytes (Volterra & Meldolesi, 2005). 
Using microdialysis, increased levels of in situ extracellular glutamate have been found in 
sclerotic seizure foci (During & Spencer, 1993; Cavus et al.; 2002). Moreover, the down-
regulation of EAAT1 and EAAT2 has also been reported (Proper et al.; 2002). However, other 
groups were unable to confirm this observation (Tessler et al.; 1998).  
In sclerotic astrocytes, the GABA transporter GAT3 is up-regulated. In the same vein, 
microdialysis in epileptic patients has revealed decreased levels of extracellular GABA in 
the epileptic foci during the ictal state (During & Spencer 1993). The increased expression of 
the transporter would help to reduce extracellular GABA levels, thereby decreasing 
inhibitory tone during the ictal state. 
Expression of the protein AQP4 is reduced on the perivascular membrane of the astrocyte in 
sclerotic hippocampi, whereas its expression is unchanged on the membrane that faces the 
neuropil. This change may cause a decrease in water extrusion from the neuropil to the 
vessel (Eid et al.; 2005). 
In addition to changes in the expression of transport proteins in epileptic foci, ion channels 
in astrocytes are also modified. Cultured astrocytes obtained from patient hippocampus and 
entorhinal cortex1 displayed much larger tetrodotoxin (TTX)-sensitive Na+ currents than 
astrocytes from non-sclerotic hippocampi (O’connor et al.; 1998). However, as with other 
results, there are discrepancies regarding the increased Na+ current (Hinterkeuser et al.; 
2000). Changes in the differential expression of calcium channels have been reported in the 
sclerotic hippocampus, but the functional significance of this change remains unclear (de 
Lanerolle et al.; 2010). 
Impaired K+ buffering has been detected in sclerotic patient hippocampi, suggesting that 
there are defective channels in the sclerotic region, particularly in CA1 (Gabriel et al.; 1998). 
The buffering of K+, which is likely performed by the GFAP+ subset of Glu-like astrocytes 
(and carried out by the Kir channels), depends on a parallel flux of water through the 
plasma membrane to avoid hyperosmolarity. Water molecules and K+ are taken up by the 
astrocytic membrane of the neuropil and pushed into the blood and cerebrospinal fluid 
(CSF) through the end-food pole. A loss of AQP4 would impede the movement of water and 
contribute to increased [K+]o. Concomitantly, the down-regulation of Kir4.1 channels during 
a critical time window has been described in a rat model of epilepsy (Ivens et al.; 2007), as 
we discuss in detail below. Clearly, this process can contribute to further increase the 
concentration of extracellular K+. 
4.2 Changes in genes expression and metabolism 
In the sclerotic hippocampus, changes in various enzymes that are involved in the 
metabolism of astrocytes and the interaction between astrocytes and neurons have been 
                                                                 
1The entorhinal cortex is part of the parahippocampal gyrus and is the main source of input to the 
hippocampus through the perforant pathway and the collaterals of the temporoammonic pathway. 
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described (Herrera-Peco et al.; 2008). In this regard, a loss of glutamine synthetase in CA1 
and CA3, an increase in the activity of glutamate dehydrogenase and/or a decrease in the 
activity of lactate dehydrogenase have all been reported. Besides, extracellular levels of 
lactate are elevated in the sclerotic hippocampus (de Lanerolle et al.; 2010). 
On the other hand, several astrocyte-related genes are up-regulated in sclerotic regions. 
These changes in the pattern of gene expression are consistent with increased gliosis or 
immune and inflammatory responses (Lee et al.; 2007). This is discussed in detail below. 
It is likely that much of these changes are a consequence of epilepsy rather than a cause. 
Therefore, more data are needed before we can formulate an exact picture of the genetic 
changes that are related to epileptogenesis. 
4.3 Changes in BBB permeability 
It has long been recognized that there is a proliferation of the microvasculature in the sclerotic 
hippocampus, an observation that has been recently confirmed (Rigau et al.; 2007). However, 
on the contrary, there are recent reports showing a significant loss of microvessels in the CA1 
region of sclerotic hippocampi (Kastanauskaite et al.; 2009). In any case, most groups agree on 
the presence of blood vessel changes in TLE-associated hippocampal sclerosis.  
Several molecules that are located in the perivascular end-feet exhibit changes in sclerotic 
regions. AQP4 and dystrophin are reduced, whereas CD44 and plectin 1 are increased. 
Other molecules such as the chemokines CCL2 and CCL3 are up-regulated, as are the 
chemokine receptors CCR1 and CCR2 (de Lanerolle, 2010).  
It is believed that these glial-derived chemokines can guide circulating leukocytes through 
endothelial junctions and into the brain’s extracellular space. These chemokines can also help 
mediate the extravasation of albumin (de Lanerolle et al.; 2010). Therefore, these changes can 
alter the permeability of the BBB, thereby allowing molecules that normally are excluded to 
access the brain. Indeed, it has been shown that the BBB is leakier during seizures (de 
Lanerolle et al.; 2010). Furthermore, immunohistochemical localization of albumin in resected 
hippocampi from TLE patients showed strong albumin immunoreactivity in the parenchyma 
throughout the hippocampus next to the blood vessels. Neurons and astrocytes located 
around the vessels were also albumin-positive, thus demonstrating an increase in BBB 
permeability. Such extravasations of albumin were not observed in control hippocampi (van 
Vliet et al.; 2007). In an animal model, the extravasation of serum albumin to the brain’s 
extracellular space was associated with a prominent activation of astrocytes, but no 
inflammatory response or marked cell loss. This activation was associated with the 
development of epileptiform discharges within 4–7 days (Seiffert et al.; 2004).  
Changes other than permeability have been reported in the BBB. The erythropoietin receptor 
is strongly expressed in the capillaries of sclerotic hippocampi, which suggests an increased 
uptake of erythropoietin into the hippocampus (Eid et al.; 2004). 
4.4 Inflammatory and immune responses in the brain 
Astrocytes contribute to the inflammatory response in the CNS. Glial cells can produce a 
range of immunologically relevant molecules, including class II major histocompatibility 
complex antigens, cytokines and chemokines. Studies have shown that glial cells—including 
both astrocytes and microglia—express high levels of pro-inflammatory cytokines in regions 
that are recruited in the generation and propagation of seizures. In astrocytes and microglia 
of patients with TLE and hippocampal sclerosis, the IL-1β system is activated, particularly in 
end-feet perivascular regions and in endothelial cells in sclerotic brain regions (Ravizza et 
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al.; 2007). These changes can affect the permeability of the BBB, perhaps by disrupting tight-
junction organization (Del Machio et al.; 1996). It has been showed that IL-1β has a pro-
ictogenic role that is mediated by the receptor IL-1R1 (Vezzani et al.; 2002). Exposure to IL-
1β or TNF-α exacerbates the excitotoxic neuronal damage that is induced by NMDA or 
AMPA, thus suggesting that cell survival depends on the tissue concentration and duration 
of action of cytokines. This deleterious effect is mediated by the induction of toxic mediators 
to affect neuronal excitability. 
The damage in the brain that is induced by IL-1β can be mediated by an increase in the 
function of NMDA receptors or by an increase in extracellular glutamate. In this sense, IL-1β 
increases NMDA-mediated Ca2+ influx into neurons, thereby promoting excitotoxicity 
(Vezzani et al.; 2008). Other well-established mechanisms include the inhibition of 
glutamate uptake by glial cells and an increase in glutamate release via TNF-α production 
(Bezzi et al.; 2001). Additionally, IL-1β activates nitric oxide (NO) synthase, increasing the 
glutamate release. Presumably, all of these mechanisms lead to increased glutamatergic 
transmission and toxicity. However, GABAergic transmission is also affected by 
inflammation. Indeed, IL-1β has been shown to inhibit GABAA receptors, thereby 
contributing to hyperexcitability (Wang et al.; 2000). 
Other cytokines that are produced by glial cells—such as IL-6, TNF-α and prostaglandins—
have been shown to have either pro-ictogenic or inhibitory effects on seizures in a 
concentration-dependent manner, and this depends on the type of receptors involved and 
the origin of the cells (Vezzani et al.; 2008). It has been reported that TNF-α activates the 
rapid recruitment AMPA receptors that lack the GluR2 subunit to the neuronal membrane; 
this molecular conformation is permissive for Ca2+ influx, thereby increasing neurotoxicity. 
Moreover, in the sclerotic hippocampus, there is an up-regulation of the p65 subunit of the 
nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) (Crespel et al.; 2002), 
a protein complex that control DNA transcription and is involved in the cellular responses 
to stress. In the sclerotic hippocampus, immunoreactivity of complement proteins was 
increased in regions of neuronal loss (including CA1, CA3 and the hylus of the dentate 
gyrus). All of these data imply a direct participation of the inflammatory pathway in 
epilepsy. 
4.5 The participation of albumin in the activation of astrocytes 
Albumin is usually not in contact with astrocytes or neurons. Indeed, its concentration in the 
extracellular space of the CNS (∼35 ng/ml) is three orders of magnitude lower than in blood 
(Nadal et al.; 2001). The effect of albumin on glial cells depends on both the protein itself 
and the lipids to which it is attached (Nadal et al.; 1995; 1997). 
Recently, it was elegantly demonstrated in rats that albumin can act directly on astrocytes, 
thereby facilitating epileptogenesis (Seiffert et al.; 2004, Ivens et al.; 2007; Van Vliet et al.; 
2007). It has been shown that direct brain exposure to serum albumin is associated with 
albumin uptake into astrocytes that is mediated by TGF-ǃR. This uptake is followed by the 
down-regulation of Kir4.1 channels in astrocytes, which results in reduced buffering of 
extracellular potassium. This in turn leads to an increased activity-dependent accumulation 
of extracellular potassium, which results in facilitated NMDAR–mediated neuronal 
hyperexcitability and ultimately epileptiform activity (Ivens et al.; 2007). Presumably, these 
effects are mediated by GFAP+/GluT astrocytes. On the other hand, albumin can act on 
NG2/GluR astrocytes; in these cells, TGF-ǃR can induce the transcription factor NF-κB, 
which can modify the expression of cyclooxygenase 2 (COX-2).  
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However, albumin can act on astrocytes through a pathway that is distinct from TGF-ǃR. 
This pathway has not been extensively explored; however, changes in [Ca2+]i can induce 
new DNA synthesis in cultured astrocytes (Pastor et al.; 2010). It is therefore reasonable to 
speculate that changes in gene expression that are observed during epileptogenesis in rats 
are induced by the calcium-dependent pathway and not only through the action of TGF-ǃR. 
4.6 The role of adenosine kinase in epileptogenesis 
Inhibitory neuromodulation by adenosine is primarily mediated by the activation of A1 
receptors that are coupled to inhibitory Gi and Go G-proteins. As a result, the release of 
glutamate and others neurotransmitters is inhibited. In addition, A1 receptor activation can 
decrease brain metabolism and alter astrocytic function, thereby conferring beneficial effects 
(Haberg et al.; 2000; van Claker & Biber, 2005). In contrast to A1 receptors, A2A receptors are 
coupled to excitatory Gs and Golf G-proteins and both excitatory and inhibitory responses 
have been reported (Boison, 2008). The activity of this type of receptor is restricted to active 
synapses. Stimulating nerve terminals at a high frequency can release ATP, which can be 
degraded to adenosine, which in turn acts by binding to A2A receptors. Subsequent 
activation of A2A can lead to the down-regulation of A1 receptors. With respect to the low-
affinity A2B and low-density A3 receptors, it appears that these receptors may only be 
relevant under pathological conditions, for example following traumatic brain injury or 
during cerebral ischemia (Pearson et al.; 2006). In summary, the extracellular level of 
adenosine has an important role in seizure threshold. 
Astrocytes play a key role in regulating the levels of extracellular adenosine (Boison 2006; 
Haydon & Carmignoto, 2006); this is presumably via an adenosine cycle that involves the 
vesicular release of ATP, extracellular degradation to adenosine, uptake of adenosine via 
nucleoside transporters and intracellular phosphorylation of AMP (Boison, 2008). It is 
known that astrocytes are the primary source of ATP under physiological conditions, thus 
favoring a relative tone of inhibition within the neural network. 
Extracellular levels of adenosine can be regulated by reuptake through nucleoside 
transporters, which can be divided into three isoforms of concentrative nucleoside 
transporters (CNT1, 2 and 3) that are coupled to the Na+ gradient and into four isoforms of 
equilibrative nucleoside transporters (ENT1 through ENT4) (Smith et al.; 2007). Under 
physiological conditions, ENTs appear to play a central role in controlling the extracellular 
level of adenosine in the brain. 
Once adenosine is transported into the astrocyte, it is phosphorylated by adenosine kinase 
(ADK), an enzyme that is almost exclusively expressed in these glial cells in the adult brain 
(Studer et al.; 2006).  
Adenosine kinase has a biphasic response to stress after a brain injury (Boison, 2008): 
• First, ADK is rapidly down-regulated, leading to an elevated level of adenosine. This 
enhancement serves as a protective factor via the activation of A1 receptors. This 
increase in extracellular adenosine might be a general astrocyte-based mechanism to 
protect the brain after stroke, ischemia, status epilepticus, or a similar condition. 
• In the second phase, there is an up-regulation of ADK that leads to a significant 
decrease in the level of extracellular adenosine, thereby reducing the tone of the A1 
receptors. This up-regulation of ADK is accompanied by parallel changes in G-protein–
coupled receptors, for example, down-regulation of A2 receptors or increased 
expression of GABAB receptors. 
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It has been shown that increased levels of adenosine may induce or trigger astrogliosis by 
effect that appears to be largely mediated by A2A receptors. Thus, activation of this receptor 
type potentiates the synaptic action of brain-derived neurotrophic factor (BDNF) in the 
hippocampus (Diogenes et al.; 2007), stimulates glutamate outflow and leads to excessive 
glial activation, ultimately inducing astrocytosis. Indeed, it has been shown that stimulating 
A2A receptors during brain injury (e.g.; hypoxia or inflammation) directly leads to gliosis 
(Cunha, 2005). Thus, it can be stated that astrogliosis is a consequence of acute ADK down-
regulation. This state can be chronically maintained, allowing the development and 
persistence of chronic epilepsy and ultimately drug resistance. In summary, a common 
consequence of brain injury is astrogliosis, which can be considered the most prominent 
astroglial response to CNS damage (Pekny & Nilsson, 2005) and a hallmark of the epileptic 
brain, being present in up to 90% of surgically resected hippocampi (Thom et al.; 2002), and 
it has been proposed to be an important factor both in the development of seizures and in 
the persistency of seizure disorders. Moreover, neuronal cell loss and astrogliosis can 
propagate to other parts of the limbic system, including the amygdala and perirhinal cortex 
(Wieser, 2004). However, this causal relationship between astrogliosis, ADK up-regulation 
and epilepsy was recently discussed. A recent report presented evidence that the global 
expression levels of ADK are more closely related to epilepsy than to astrogliosis, per se (Li 
et al.; 2008). 
4.7 A global portrait of the process 
All of these data can be summarized as follows. Various types of injury, including bleeding, 
ischemia, infectious disease and traumatic injury, can alter the permeability of the BBB. In 
inflammatory or infectious disease, activation of leukocytes can induce the release of 
chemokines, thereby changing permeability. In other cases (for example, after brain trauma), 
the anatomical dysfunction of capillaries is the first step. As a consequence, albumin, which 
is physiologically excluded from the brain, might efflux from the vessels. In the processes 
that are associated with coagulation (e.g.; intracranial bleeding), albumin can bind to LPA or 
other platelet-derived lipids. However, at least in the initial steps, other processes such as 
mechanical disruption of the BBB are not associated with coagulation; in this case, albumin 
would not need to be attached to lipids that are produced after platelet activation. As a 
consequence of BBB breakdown, albumin will enter the extracellular space of the brain, 
where it can interact with cells that normally do not have contact. The interaction with 
NG2/GluR astrocytes will modify the expression of COX2 and subsequently PGE2, thereby 
inducing glutamate release through a Ca2+-dependent mechanism. NG2 cells are present 
and accumulate in the sclerotic hippocampus. Neuronal activity, however, can depolarize 
NG2 cells, thereby allowing the influx of Ca2+, thereby increasing [Ca2+]i and glutamate 
release. Thus, it has been suggested that the presence of NG2/GluR cells in the sclerotic 
hippocampus can help to increase excitability and/or facilitate the propagation of a 
depolarization wave. 
On the other hand, albumin will bind to either TGF-ǃR or albumin receptors in 
GFAP+/GluT astrocytes. In the former case, albumin will be taken into the astrocyte and 
transported to the nucleus, where it will induce various modifications in gene expression. 
We can speculate, in the second case, that albumin acting through the albumin receptor will 
increase [Ca2+]i, which in turn would act as a second messenger in affecting gene expression, 
including down-regulation of AQP4 in the BBB lumen, glutamine synthetase and Kir4.1 
channels. As a consequence of these changes, extracellular glutamate and [K+]o would 
www.intechopen.com
 Underlying Mechanisms of Epilepsy 36
increase These modifications in the external milieu will lead to changes in the excitability of 
neurons, presumably by modifying NMDA function. 
In addition to changing extracellular albumin concentration, the primary injury can lead 
to a general protective reaction that consists of ADK down-regulation. If the injure is not 
too severe, general homeostatic mechanisms might control and reverse this process. 
However, if the damage is severe enough, the down-regulation will be followed by an up-
regulation of ADK, thereby decreasing the anticonvulsant effect of adenosine and 
triggering the appearance of astrogliosis, followed by recurrent seizures and resistance to 
drugs. 
5. Discussion and conclusions 
We have revisited some diverse aspects related to epilepsy and astrocytes, including 
changes in gene expression patterns, integral membrane proteins and vasculature 
permeability in the brain. Presently, one cannot be certain which of these changes are causal 
or consequential to the epileptic process is. However, there cannot be doubt with regard to 
the participation of these changes in the disease.  
The ultimate cause of epilepsy is most likely multifactorial and is both intrinsic (e.g.; 
genetics) and extrinsic (e.g.; stroke, inflammation, infection); however, for the first time we 
can now present an overview of many of the processes that lead from a normal brain to an 
epileptic brain. 
There can be no doubt that considering this process is extremely important. Properly 
understanding the process of epileptogenesis might lead to the development of new 
approaches directed at preventing the appearance of a first seizure or recurrent seizures 
after a window period, addressing the increased permeability in the BBB or the efflux of 
albumin into the brain and perhaps blocking of the astrocytes with agents directed against 
either the TGF-ǃ or calcium-dependent pathway. In this same vein— but perhaps a bit more 
delayed in the therapy cascade—new pharmacological approaches for increasing the 
anticonvulsant effects of adenosine can be studied. 
However, therapeutics is not the only potential benefit of the emergence of this theory. 
Diagnosis can be improved by measuring the levels of molecules in the brain by PET or 
SPECT scanning. For example, the levels of adenosine or TGF-ǃ receptors in patients may be 
measured in the future, which could be valuable in identifying the epileptic zone in patients 
who are being evaluated for epilepsy surgery. 
A large body of data has been gleaned from animal models. However, animal models and 
the human pathology are not exactly equivalent; therefore, most of these hypothesis must be 
tested in humans, where the actual illness occurs. It is important to keep this point in mind if 
we wish to provide relief to epileptic patients. In this sense, it has been shown in humans 
that cortical slowing is a typical finding after a mild traumatic brain injury, and this may be 
associated with persistently increased BBB permeability and a regional cerebral blood flow 
(rCBF) deficit (Korn et al.; 2005). 
The general portrait that has been outlined in this chapter likely raises as many questions as 
it answers. For example: 
• Is this model correct in human patients? Obviously, this is the most important question. 
Several lines of evidence suggest that this model— or a modified model—could be 
responsible for partial epilepsies in humans. However, this hypothesis needs to be 
demonstrated definitively. 
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• Is there any difference between plasma and serum albumin? It is likely that not all CNS 
injuries will be associated with coagulation. Therefore, it is important to discern which 
mechanism of astrocyte activation (TGF-ǃR or calcium-dependent) is acting in a given 
pathological condition. 
• Which of these pathways (TGF-ǃR or calcium-dependent), if any, act in humans? Do 
both pathways act in all epileptogenic processes, or do they act differentially depending 
on the etiology? 
• What is the role of astrogliosis in epilepsy? Is it merely a finding or a causal process? 
To summarize, we can affirm that astrocytes are undoubtedly very important players in the 
process of epileptogenesis, although their true role still needs to be completely uncovered. 
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